EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Pulmonary Alveolar Microlithiasis: From Clinicopathologic Description to Molecular Pathogenesis and Emerging Therapies

Kseniia Malkova, Mylene T. Truong, Cesar A. Moran

Journal of Respiration · 2026-11-12 · 6 (4) · 31

DOI: 10.3390/jor6040031 ↗
AbstractBibliografische Angaben

Abstract

Pulmonary alveolar microlithiasis (PAM) is a rare autosomal recessive lung disease in which calcium phosphate microliths fill the alveoli; more than 1000 cases have been reported worldwide. Although its cause remained unknown for decades, loss-of-function variants in SLC34A2, which encodes the sodium-phosphate cotransporter NPT2b, are now known to explain nearly all genetically tested cases; failure to clear phosphate from the alveolar lining fluid leads to microlith formation, and an epithelial Npt2b-knockout mouse reproduces the human phenotype. Diagnosis now rests mainly on characteristic high-resolution CT and, increasingly, on genotyping rather than lung biopsy. The course is usually slow but variable; in published series followed for 10 to 49 years after diagnosis, a substantial proportion of patients, though not all, progressed to respiratory failure, whereas others remained stable for decades. No drug has proven efficacy; lung transplantation is the only established therapy for end-stage disease, and no allograft recurrence has been documented. Preclinical data support phosphate restriction, EDTA lavage and gene-directed approaches. However, controlled trials with more genotype–phenotype correlation and prospective natural-history data are still needed.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →